Following DNA damage cells activate a multi-faceted response including cell cycle arrest and the coordinated activation of DNA repair. Failure to activate or to coordinate the DNA-damage induced signal transduction pathways can lead to chromosome breakage and loss, and to the propagation of mutations. Indeed, several cancer-prone syndromes reflect defects in the DNA damage response. These include, but are not limited to, Ataxia-Telangiectasia, Nijmegen Breakage Syndrome, Ataxia-Telangiectasia Like Disorder, Li-Fraumeni Syndrome and familial forms of breast and cervical cancers. Our long-term objective is to understand the mechanisms by which the different facets of the DNA damage response are integrated within cell cycle progression at the time of DNA replication. The ability to undergo DNA replication in the presence of DNA damage, called Radio-Resistant DNA Synthesis (RDS), is a hallmark of the cellular phenotypes of cancer-prone disorder as well as of tumor cells. We have established a cell-free system derived from Xenopus eggs that recapitulates different aspects of the DNA damage response. In particular, we have been able to identify a novel ATM- dependent cell cycle checkpoint that prevents initiation of DNA replication. We will determine whether the Xenopus homologues of Chk1 and/or Chk2/Cds1 are components of this pathway. We will also determine whether Wee1, Myt1 and/or Cdc25 are components of the pathway. We will take advantage of this cell-free system to identify which type of damages can elicit a checkpoint in vitro and whether such responses are ATM or ATR-dependent. Finally, we will examine how ATM and Mre11 complex participate in the coordinated and harmonious response to DNA damage and how cell cycle arrest is integrated with DNA repair. We anticipate that these studies will help understand some of the biochemical pathways activated by DNA damage and that, in turn; it will provide valuable information on how the DNA damage response can be impaired or lost in the case of cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA092245-01A1
Application #
6474921
Study Section
Radiation Study Section (RAD)
Program Officer
Pelroy, Richard
Project Start
2002-04-01
Project End
2007-03-31
Budget Start
2002-04-01
Budget End
2003-03-31
Support Year
1
Fiscal Year
2002
Total Cost
$288,778
Indirect Cost
Name
Columbia University (N.Y.)
Department
Genetics
Type
Schools of Medicine
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Aparicio, Tomas; Baer, Richard; Gottesman, Max et al. (2016) MRN, CtIP, and BRCA1 mediate repair of topoisomerase II-DNA adducts. J Cell Biol 212:399-408
Sato, Mai; Rodriguez-Barrueco, Ruth; Yu, Jiyang et al. (2015) MYC is a critical target of FBXW7. Oncotarget 6:3292-305
Aparicio, Tomas; Baer, Richard; Gautier, Jean (2014) DNA double-strand break repair pathway choice and cancer. DNA Repair (Amst) 19:169-75
Rozier, Lorene; Guo, Yige; Peterson, Shaun et al. (2013) The MRN-CtIP pathway is required for metaphase chromosome alignment. Mol Cell 49:1097-107
Williams, Hannah L; Gottesman, Max E; Gautier, Jean (2013) The differences between ICL repair during and outside of S phase. Trends Biochem Sci 38:386-93
Srinivasan, Seetha V; Dominguez-Sola, David; Wang, Lily C et al. (2013) Cdc45 is a critical effector of myc-dependent DNA replication stress. Cell Rep 3:1629-39
Peterson, Shaun E; Li, Yinyin; Wu-Baer, Foon et al. (2013) Activation of DSB processing requires phosphorylation of CtIP by ATR. Mol Cell 49:657-67
Williams, Hannah L; Gottesman, Max E; Gautier, Jean (2012) Replication-independent repair of DNA interstrand crosslinks. Mol Cell 47:140-7
Peterson, Shaun E; Li, Yinyin; Chait, Brian T et al. (2011) Cdk1 uncouples CtIP-dependent resection and Rad51 filament formation during M-phase double-strand break repair. J Cell Biol 194:705-20
Srinivasan, Seetha V; Gautier, Jean (2011) Study of cell cycle checkpoints using Xenopus cell-free extracts. Methods Mol Biol 782:119-58

Showing the most recent 10 out of 32 publications